These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 28137646)
1. Loss of nitrergic and cholinergic neurons in the enteric nervous system of APP/PS1 transgenic mouse model. Han X; Tang S; Dong L; Song L; Dong Y; Wang Y; Du Y Neurosci Lett; 2017 Mar; 642():59-65. PubMed ID: 28137646 [TBL] [Abstract][Full Text] [Related]
2. Unique expression pattern of KIBRA in the enteric nervous system of APP/PS1 mice. Feng J; Dong L; Zhang J; Han X; Tang S; Song L; Cong L; Wang X; Wang Y; Du Y Neurosci Lett; 2018 May; 675():41-47. PubMed ID: 29526515 [TBL] [Abstract][Full Text] [Related]
3. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice. Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660 [TBL] [Abstract][Full Text] [Related]
4. Loss of Cholinergic and Monoaminergic Afferents in Lee MK; Chen G Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732223 [TBL] [Abstract][Full Text] [Related]
5. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037 [TBL] [Abstract][Full Text] [Related]
6. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease. Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of mutant amyloid-β protein precursor and presenilin 1 modulates enteric nervous system. Puig KL; Lutz BM; Urquhart SA; Rebel AA; Zhou X; Manocha GD; Sens M; Tuteja AK; Foster NL; Combs CK J Alzheimers Dis; 2015; 44(4):1263-78. PubMed ID: 25408221 [TBL] [Abstract][Full Text] [Related]
8. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589 [TBL] [Abstract][Full Text] [Related]
10. Neural stem cell transplantation improves learning and memory by protecting cholinergic neurons and restoring synaptic impairment in an amyloid precursor protein/presenilin 1 transgenic mouse model of Alzheimer's disease. Zhu Q; Zhang N; Hu N; Jiang R; Lu H; Xuan A; Long D; Chen Y Mol Med Rep; 2020 Mar; 21(3):1172-1180. PubMed ID: 31922229 [TBL] [Abstract][Full Text] [Related]
11. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Liu HL; Zhao G; Zhang H; Shi LD Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591 [TBL] [Abstract][Full Text] [Related]
12. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease. Hamilton A; Holscher C Brain Res; 2012 Apr; 1449():83-93. PubMed ID: 22418058 [TBL] [Abstract][Full Text] [Related]
13. Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model. Jiao SS; Bu XL; Liu YH; Zhu C; Wang QH; Shen LL; Liu CH; Wang YR; Yao XQ; Wang YJ Neurotox Res; 2016 Feb; 29(2):256-66. PubMed ID: 26707129 [TBL] [Abstract][Full Text] [Related]
14. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease. Howlett DR; Bowler K; Soden PE; Riddell D; Davis JB; Richardson JC; Burbidge SA; Gonzalez MI; Irving EA; Lawman A; Miglio G; Dawson EL; Howlett ER; Hussain I Histol Histopathol; 2008 Jan; 23(1):67-76. PubMed ID: 17952859 [TBL] [Abstract][Full Text] [Related]
15. Cholinergic neurodegeneration in an Alzheimer mouse model overexpressing amyloid-precursor protein with the Swedish-Dutch-Iowa mutations. Foidl BM; Do-Dinh P; Hutter-Schmid B; Bliem HR; Humpel C Neurobiol Learn Mem; 2016 Dec; 136():86-96. PubMed ID: 27670619 [TBL] [Abstract][Full Text] [Related]
17. The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer's disease. Zheng H; Zhou Q; Du Y; Li C; Xu P; Lin L; Xiao J; Gao H Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):263-273. PubMed ID: 29107091 [TBL] [Abstract][Full Text] [Related]
18. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease. Dikranian K; Kim J; Stewart FR; Levy MA; Holtzman DM Int J Clin Exp Pathol; 2012; 5(6):482-95. PubMed ID: 22949930 [TBL] [Abstract][Full Text] [Related]
19. Effects of diabetes mellitus on myenteric neuronal density and sodium channel expression in the rat ileum. Brasileiro AD; Garcia LP; de Carvalho da Silva S; Rocha LB; Pedrosa AL; Vieira AS; da Silva VJD; Rodrigues ARA Brain Res; 2019 Apr; 1708():1-9. PubMed ID: 30500400 [TBL] [Abstract][Full Text] [Related]
20. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]